Does protein expression predict recurrence of benign World Health Organization grade I meningioma?

Human Pathology

Volumn 41, Issue 2, 2010, Pages 199-207

  Kärjä, Vesa ^a,b   Sandell, Pär Johan ^a   Kauppinen, Tarja ^b   Alafuzoff, Irina ^a,b,c  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Beningn meningioma; Immunohistochemistry; Protein expression; Recurrence

Indexed keywords

GROWTH FACTOR RECEPTOR;

ADULT; ARTICLE; CANCER GRADING; CANCER RECURRENCE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PROGNOSIS; PROTEIN EXPRESSION; RECURRENT DISEASE; TISSUE MICROARRAY; WORLD HEALTH ORGANIZATION;

CHI-SQUARE DISTRIBUTION; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; TISSUE ARRAY ANALYSIS; WORLD HEALTH ORGANIZATION;

EID: 73749083927     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.06.020     Document Type: Article

References (37)

1. Jaaskelainen J. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26 (1986) 461-469
2. Jaaskelainen J., Haltia M., and Servo A. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25 (1986) 233-242
3. Aguiar P.H., Tsanaclis A.M., Tella Jr. O.I., and Plese J.P. Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1: correlation with peritumoural oedema and other clinicoradiological and histological characteristics. Neurosurg Rev 26 (2003) 221-228
4. Amatya V.J., Takeshima Y., Sugiyama K., et al. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas. Hum Pathol 32 (2001) 970-975
5. Devaprasath A., and Chacko G. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas. Neurol India 51 (2003) 336-340
6. Ho D.M., Hsu C.Y., Ting L.T., and Chiang H. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 94 (2002) 1538-1547
7. Kalala J.P., Caemaert J., and De Ridder L. Primary resected meningiomas: relapses and proliferation markers. In Vivo 18 (2004) 411-416
8. Matsuno A., Nagashima T., Matsuura R., et al. Correlation between MIB-1 staining index and the immunoreactivity of p53 protein in recurrent and non-recurrent meningiomas. Am J Clin Pathol 106 (1996) 776-781
9. Torp S.H., Lindboe C.F., Gronberg B.H., Lydersen S., and Sundstrom S. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas. Clin Neuropathol 24 (2005) 170-174
10. Maiuri F., De Caro Mdel B., Esposito F., et al. Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors. J Neurooncol 82 (2007) 63-68
11. Bruna J., Brell M., Ferrer I., Gimenez-Bonafe P., and Tortosa A. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma. Neuropathology 27 (2007) 114-120
12. Vankalakunti M., Vasishta R.K., Das Radotra B., and Khosla V.K. MIB-1 immunolabeling: a valuable marker in prediction of benign recurring meningiomas. Neuropathology 27 (2007) 407-412
13. Konstantinidou A.E., Korkolopoulou P., Kavantzas N., et al. Mitosin, a novel marker of cell proliferation and early recurrence in intracranial meningiomas. Histol Histopathol 18 (2003) 67-74
14. Konstantinidou A.E., Patsouris E., Korkolopoulou P., Kavantzas N., Mahera H., and Davaris P. DNA topoisomerase IIalpha expression correlates with cell proliferation but not with recurrence in intracranial meningiomas. Histopathology 39 (2001) 402-408
15. Korshunov A., Shishkina L., and Golanov A. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases. Arch Pathol Lab Med 126 (2002) 1079-1086
16. Hunt D.P., Freeman A., Morris L.S., et al. Early recurrence of benign meningioma correlates with expression of mini-chromosome maintenance-2 protein. Br J Neurosurg 16 (2002) 10-15
17. Kalala J.P., Maes L., Vandenbroecke C., and de Ridder L. The hTERT protein as a marker for malignancy in meningiomas. Oncol Rep 13 (2005) 273-277
18. Maes L., Lippens E., Kalala J.P., and de Ridder L. The hTERT-protein and Ki-67 labelling index in recurrent and non-recurrent meningiomas. Cell Prolif 38 (2005) 3-12
19. Smith J.S., Lal A., Harmon-Smith M., Bollen A.W., and McDermott M.W. Association between absence of epidermal growth factor receptor immunoreactivity and poor prognosis in patients with atypical meningioma. J Neurosurg 106 (2007) 1034-1040
20. Martinez-Rumayor A., Arrieta O., Guevara P., et al. Coexpression of hepatocyte growth factor/scatter factor (HGF/SF) and its receptor cMET predict recurrence of meningiomas. Cancer Lett 213 (2004) 117-124
21. Loussouarn D., Brunon J., Avet-Loiseau H., Campone M., and Mosnier J.F. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study. Hum Pathol 37 (2006) 415-421
22. Ucar T., and Gurer I. Prognostic importance of transferrin receptor expression and correlation with K1-67 labelling indices in intracranial meningiomas. Br J Neurosurg 17 (2003) 525-529
23. Hakin-Smith V., Battersby R.D., Maltby E.L., Timperley W.R., and Royds J.A. Elevated p53 expression in benign meningiomas protects against recurrence and may be indicative of senescence. Neuropathol Appl Neurobiol 27 (2001) 40-49
24. Konstantinidou A.E., Pavlopoulos P.M., Patsouris E., Kaklamanis L., and Davaris P. Expression of apoptotic and proliferation markers in meningiomas. J Pathol 186 (1998) 325-330
25. Muller P., Henn W., Niedermayer I., et al. Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas. Clin Cancer Res 5 (1999) 3569-3577
26. Bouvier C., Liprandi A., Colin C., et al. Lack of alkaline phosphatase activity predicts meningioma recurrence. Am J Clin Pathol 124 (2005) 252-258
27. Verheijen F.M., Donker G.H., Viera C.S., et al. Progesterone receptor, bc1-2 and bax expression in meningiomas. J Neurooncol 56 (2002) 35-41
28. Okamoto H., Li J., Vortmeyer A.O., et al. Comparative proteomic profiles of meningioma subtypes. Cancer Res 66 (2006) 10199-10204
29. Levicar N., Strojnik T., Kos J., Dewey R.A., Pilkington G.J., and Lah T.T. Lysosomal enzymes, cathepsins in brain tumor invasion. J Neurooncol 58 (2002) 21-32
30. Trinkaus M., Vranic A., Dolenc V.V., and Lah T.T. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas. Int J Biol Markers 20 (2005) 50-59
31. Strojnik T., Zidanik B., Kos J., and Lah T.T. Cathepsins B and L are markers for clinically invasive types of meningiomas. Neurosurgery 48 (2001) 598-605
32. Konstantinidou A.E., Korkolopoulou P., Mahera H., et al. Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival. Histopathology 43 (2003) 280-290
33. Strik H.M., Strobelt I., Pietsch-Breitfeld B., Iglesias-Rozas J.R., Will B., and Meyermann R. The impact of progesterone receptor expression on relapse in the long-term clinical course of 93 benign meningiomas. In Vivo 16 (2002) 265-270
34. Wolfsberger S., Doostkam S., Boecher-Schwarz H.G., et al. Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature. Neurosurg Rev 27 (2004) 238-245
35. Kuusisto E., Kauppinen T., and Alafuzoff I. Use of p62/SQSTM1 antibodies for neuropathological diagnosis. Neuropathol Appl Neurobiol 34 (2008) 169-180
36. Karja V., and Alafuzoff I. Protein p62 common in invaginations in benign meningiomas-a possible predictor of malignancy. Clin Neuropathol 25 (2006) 37-43
37. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20 (1957) 22-39